Christopher Turner – Biography
Last update: March 25, 2026Executive profile
Christopher was Vice President, Clinical Development at Blueprint Medicines, and Vice President, Clinical Science at Celldex Therapeutics.
Christopher Turner is currentlyChief Medical Officer at Nuvalent - View - Nuvalent org chart
Create your alert
to follow the career of Christopher Turner.
Education
Christopher Turner has a Bachelor in Biochemistry from Bowdoin College in 1989 and a Doctor of Medicine from University of Rochester - School of Medicine and Dentistry in 1994.
They have also studied at Bowdoin College :
Find more alumni from Bowdoin College
They have also studied at University of Rochester - School of Medicine and Dentistry :
Find more alumni from University of Rochester - School of Medicine and Dentistry
More about Christopher Turner
Selected links
Do you need to know more about Christopher Turner? More results.
Participate
Social media
- Christopher Turner on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Christopher Turner
The colleagues of Christopher Turner
Company Colleagues
- At Nuvalent, Christopher Turner has 49 colleagues including James Porter (CEO), Anna Protopapas (Chairman of the Board)…
Homonyms
- Christopher Turner - Chief Executive Officer, Vogt Power - Babcock Power
- Christopher Turner - Deputy Chief Executive Officer - Cohealth
- Christopher Turner - Managing Director, Fundraising and Investor Relations Group - Warburg Pincus
Industry Colleagues
- In the Biotechnology industry, Christopher Turner has 35,762 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Christopher Turner.
Get in Touch
Here are a few tips for establishing great contacts.
